The FDA has granted an orphan drug designation to Revolo’s ‘1104, with plans for...
As the UK pharmaceutical sector adopts the VPAG scheme, the question of how this...
The NASA and US Navy-propelled company remains confident, with Defender CEO Barr...
The shelving of Biogen’s troubled Alzheimer’s drug caps a turbulent journey, wit...
Trial results for a pain medication developed by Vertex Pharmaceuticals prompted...
The U.S. government announced a long-awaited “access model” designed to blunt th...
The U.S. syphilis epidemic isn't abating, with the rate of infectious cases risi...
Never mind Kendall Square. In Massachusetts, the next miracle drug for lung canc...
Philips won't be able to sell new sleep apnea machines until it meets corrective...
Want to stay on top of the science and politics driving biotech today? Sign up t...
People who have severe pain but want to avoid the risk of opioid addiction are c...
Results announced Tuesday by Vertex bring the biopharma giant a step closer to l...
Cour Pharmaceuticals, which announced a $105 million Series A round Tuesday, is ...
Upstart sequencing company Ultima Genomics told STAT it will soon launch a line ...
The emergency room is where the United States’ social problems come home to roost.
The memory and focus problems common to depression, researchers hope, may be all...
